We are rapidly advancing our wholly owned pipeline of targets in oncology and neurodegeneration, including next generation targets that have traditionally been “undruggable.”
Categories
1WalletHub, 2023; 2WalletHub, 2024; 3U.S. Census Bureau, 2023, ACS 1Y 2022; 4WalletHub, 2024; 5Defined as per capita GDP, U.S. Bureau of Economic Analysis, 2023, U.S. Census Bureau, 2023, AdvanceCT calculations